Shares of Kindred Biosciences Inc. (KIN) are rising over 16% in pre-market today, after the company the biopharmaceutical company announced an agreement with Vaxart Inc. (VXRT) for the manufacture of Vaxart's oral vaccine candidate for COVID-19.
from RTT - Before the Bell https://ift.tt/2LMkY3P
via IFTTT
No comments:
Post a Comment